Evidence map›Paper›PMID 29880874›Full record

ArticleCell death & disease2018

The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.

Lin-Lin Ren, Ting-Ting Yan, Chao-Qin Shen, Jia-Yin Tang, Xuan Kong, Ying-Chao Wang, Jinxian Chen, Qiang Liu, Jie He, Ming Zhong and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Identification of a Novel miR-195-5p/PNN Axis in Colorectal Cancer.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Regulation and roles of FOXK2 in cancer.Frontiers in oncology · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. ChrXq27.3 miRNA cluster functions in cancer development.Journal of experimental & clinical cancer research : CR · 2021
    Review
  18. Review
  19. MiRNA-mediated EMT and CSCs in cancer chemoresistance.Experimental hematology & oncology · 2021
    Review
  20. MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lin-Lin RenState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China.
Ting-Ting YanState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China.
Chao-Qin ShenState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China.
Jia-Yin TangDepartment of Surgery, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Xuan KongState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China.
Ying-Chao WangState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China.
Jinxian ChenDepartment of Surgery, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Qiang LiuDepartment of Pathology, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Jie HeDepartment of Gastroenterology & Guangzhou Key Laboratory of Digestive Disease, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Ming ZhongDepartment of Surgery, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China. drzhongming@hotmail.com.
Hao-Yan ChenState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China. haoyanchen@sjtu.edu.cn.ORCID 0000-0001-6722-8534
Jie HongState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China. jiehong97@sjtu.edu.cn.
Jing-Yuan FangState Key Laboratory for Oncogenes and Related Genes; Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology, Ministry of Health; Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, 145 Middle Shandong Road, 200001, Shanghai, China. jingyuanfang@sjtu.edu.cn.
Shanghai Jiao Tong University · CNGuangzhou First People's Hospital · CNQingdao University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31371273National Natural Science Foundation of China (National Science Foundation of China) 31371420National Natural Science Foundation of China (National Science Foundation of China) 81402347National Natural Science Foundation of China (National Science Foundation of China) 81421001National Natural Science Foundation of China (National Science Foundation of China) 81522008National Natural Science Foundation of China (National Science Foundation of China) 81530072
6 · The paper itself

Abstract

The abnormal expression of microRNAs (miRNAs) in colorectal cancer (CRC) progression has been widely investigated. It was reported that the same hairpin RNA structure could generate mature products from each strand, termed 5p and 3p, which binds different target mRNAs. Here, we explored the expression, functions, and mechanisms of miR-514b-3p and miR-514b-5p in CRC cells and tissues. We found that miR-514b-3p was significantly down-regulated in CRC samples, and the ratio of miR-514b-3p/miR-514b-5p increased from advanced CRC, early CRC to matched normal colorectal tissues. Follow-up functional experiments illustrated that miR-514b-3p and miR-514b-5p had distinct effects through interacting with different target genes: MiR-514b-3p reduced CRC cell migration, invasion and drug resistance through increasing epithelial marker and decreasing mesenchymal marker expressions, conversely, miR-514b-5p exerted its pro-metastatic properties in CRC by promoting EMT progression. MiR-514b-3p overexpressing CRC cells developed tumors more slowly in mice compared with control cells, however, miR-514b-5p accelerated tumor metastasis. Overall, our data indicated that though miR-514b-3p and miR-514b-5p were transcribed from the same RNA hairpin, each microRNA has distinct effect on CRC metastasis.

Indexed as

AnimalsBase SequenceCell Line, TumorColorectal NeoplasmsDisease ProgressionDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMice, NudeMicroRNAsNeoplasm InvasivenessNeoplasm MetastasisMicroRNAsMIRN514 microRNA, human

Identifiers

PMID29880874
PMCPMC5992212
OpenAlexW2805163386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.